Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Treatment-adherence in bipolar disorder: A patient-centred approach.

Chakrabarti S.

World J Psychiatry. 2016 Dec 22;6(4):399-409. doi: 10.5498/wjp.v6.i4.399. Review.

2.

Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity.

Bauer R, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, Murray G, Ritter P, Lewitzka U, Severus E, Whybrow PC, Bauer M.

Int J Bipolar Disord. 2013 Dec 9;1:26. doi: 10.1186/2194-7511-1-26.

3.

Seeking insights about cycling mood disorders via anonymized search logs.

Yom-Tov E, White RW, Horvitz E.

J Med Internet Res. 2014 Feb 25;16(2):e65. doi: 10.2196/jmir.2664.

4.

Medication adherence in a comparative effectiveness trial for bipolar disorder.

Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, Ostacher MJ, Keyes M, Rabideau D, Nierenberg AA.

Acta Psychiatr Scand. 2014 May;129(5):359-65. doi: 10.1111/acps.12202.

5.

Extreme attributions predict the course of bipolar depression: results from the STEP-BD randomized controlled trial of psychosocial treatment.

Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Nierenberg AA, Deckersbach T.

J Clin Psychiatry. 2013 Mar;74(3):249-55. doi: 10.4088/JCP.12m08019.

6.

Mindfulness-based cognitive therapy for bipolar disorder: effects on cognitive functioning.

Stange JP, Eisner LR, Hölzel BK, Peckham AD, Dougherty DD, Rauch SL, Nierenberg AA, Lazar S, Deckersbach T.

J Psychiatr Pract. 2011 Nov;17(6):410-9. doi: 10.1097/01.pra.0000407964.34604.03.

7.

Poor response to treatment: beyond medication.

Carvajal C.

Dialogues Clin Neurosci. 2004 Mar;6(1):93-103.

8.

Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.

Teter CJ, Falone AE, Bakaian AM, Tu C, Ongür D, Weiss RD.

Psychiatry Res. 2011 Dec 30;190(2-3):253-8. doi: 10.1016/j.psychres.2011.05.042.

9.

Strategies for monitoring outcomes in patients with bipolar disorder.

Ketter TA.

Prim Care Companion J Clin Psychiatry. 2010;12(Suppl 1):10-6. doi: 10.4088/PCC.9064su1c.02.

10.

A comparison of the life goals program and treatment as usual for individuals with bipolar disorder.

Sajatovic M, Davies MA, Ganocy SJ, Bauer MS, Cassidy KA, Hays RW, Safavi R, Blow FC, Calabrese JR.

Psychiatr Serv. 2009 Sep;60(9):1182-9. doi: 10.1176/ps.2009.60.9.1182.

11.

MicroRNAs in mental health: from biological underpinnings to potential therapies.

Hunsberger JG, Austin DR, Chen G, Manji HK.

Neuromolecular Med. 2009;11(3):173-82. doi: 10.1007/s12017-009-8070-5.

12.

Carbamazepine extended-release capsules in bipolar disorder.

Weisler RH.

Neuropsychiatr Dis Treat. 2006 Mar;2(1):3-11.

14.

Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review.

Lanouette NM, Folsom DP, Sciolla A, Jeste DV.

Psychiatr Serv. 2009 Feb;60(2):157-74. doi: 10.1176/appi.ps.60.2.157. Review.

15.

Modafinil Treatment of Excessive Daytime Sedation and Fatigue Associated With Topiramate.

Berigan TR.

Prim Care Companion J Clin Psychiatry. 2002 Dec;4(6):249-250. No abstract available.

Supplemental Content

Support Center